Cancer Therapy Vol 4, 271-276, 2006
How
could the light fluence rate influence the cure effect of photodynamic therapy?
Tao
Xu*, Mingzhao
Li
Academy
of Metrology and Quality Inspection of Shenzhen, GuangDong Pro, China, 510085
__________________________________________________________________________________
*Correspondence: Tao Xu, Academy of Metrology and
Quality Inspection of Shenzhen, GuangDong Pro, China, 5100; Phone:
+86-755-26941691; Fax: +86-755-26941524; E-mail:
xutao780606@126.com
Keywords: photodynamic therapy,
fluence rate, microvasculature damage, RBCs
column diameter,
Krogh tissue model
Abbreviations: bovine serum albumin, (BSA); haematoporphyrin
derivative, (HpD); optical
density, (OD); Photodynamic therapy, (PDT); RBCs
column diameter, (RBCCD)
Summary
Photodynamic therapy (PDT) is believed to act through the
cytotoxic singlet oxygen, which forms when the photosensitizer is excited by
light and transfers its energy to the molecular oxygen in tissues. It may be the principle way to destroy the tumor cell in PDT that the singlet oxygen will oxidize some elements of the cell. Photosensitizer, tissue
oxygen and irradiation light are considered to be the three
element factors of PDT (Dougherty
ea al 1998; Rosenthal and Glatstain 1994). Oxygen in tissues can be easily depleted at high fluence rates while it can be preserved
at low fluence rates (Henderson
et al 2000). And a rule has been concluded that
the higher fluence rates, the more decreasing in the oxygen concentration (Foster
et al 1991; Schunck and Poulet 2000). While how oxygen can be preserved at low fluence rates
is a puzzling problem. It is believed to have something to do with the
microvasculature.
It is noticed at the same time that at similar oxygen environment
low fluence rates cause more tumor cure than high fluence rates for the same
total fluence (Sitnik et al 1998; Foster et al 1993; Veenhuizen and Stewart 1995). Are there any other reasons that cause the higher
cure rate except oxygen? Maybe the fluence rate can influence the tumor cell killing
ability, but it needs
to be verified.
Some experiments observing the microscopic cell killing rate at different
fluence rates must be performed.
PDT impetus is also a guide to evaluate the efficiency
of therapy. The relationship between the PDT impetus and the fluence rate
should be observed. We can build a model to simulate the photodynamic reaction
process. As photodynamic reaction will stop under some oxygen level (Nichols
and Foster 1994), the threshold can be calculated to represent the PDT impetus.
By this attempt, we can find out how the fluence rate influences the reaction
process.
Works mentioned above can help us to recognize how the
fluence rate can influence the photodynamic therapy effect.
II. Materials and Method
A.
Microvasculature damage in PDT against light fluence rate
Wistar rats weighted 200±10g
(Experimental Animal Center of PLA General Hospital, Beijing, China) were
obtained at least 1 week before the experimentation. They were
housed in a room with subdued lighting and fed with a
standard pellet diet and water. Approval for this project was obtained from the
Animal Experiment Center of Tianjin Medical University. A chondrosarcoma tumor
cell line was transplanted into the right flank of each rat. The tumors that grew to be approximately 6-7 mm in size within
about 5 days after transplantation were used in this experiment.
The animals were given the haematoporphyrin derivative (HpD) via tail vein
injection at a dose of 2.5 mg kg-1. About 24 hours after the
injection the rats were anaesthetized with a 50 mg kg-1 sodium pentobarbital.
The RBCs column diameter (RBCCD) observation method described in (Fingar et al 1992, 1999;
Xu et al 2005) was employed to investigate the tumor microvasculature. The distribution of the vascular was observed by
unaided eyes and little
fatty regions with arteriole
and venule in pairs were chosen.
The RBCCD was
measured through the playback of the recorded images every 4 min for 32 min for
the 75 mW/cm2 illuminating group. For the 150 mW/cm2
illuminating group it is 2 min for 16 min.
The relative RBCs column diameter
RBCCDrel at time t was defined as RBCCD(t)/RBCCD(0).
Ten animals were used in each different experimental group and the mean
relative RBCCD at time t was thought to reflect the status of the microvasculature
after some dose of illumination.
B.
Cell killing in PDT against light fluence rate
Mammary
cancer cell MDAMB 543 was obtained from the tumor laboratory of PLA General
Hospital of China and was cultured in vitro with 90% RPMI 1640 incubation media
(GIBCOBRL Lifetechnologies, Rockville, MD, USA), 10% bovine serum albumin (BSA)
and 1% penicillin and streptomycin at 37℃. The cancer cell was laid in
incubator with 5% CO2. The cultured MDAMB 543 cells were made
suspension of single cell with 0.25% trypsase (Sigma, St Louis, MO, USA). The
cell concentration of the suspension was 1.0×105/ml. Seven
culture plates with 96 wells (Costar, Cambridge, MA, USA) were used to
inoculation the suspension in a manner of 0.2 ml per well and placed in the 5%
CO2 incubator at 37℃ for 16 hours. Then the supernatant
culture media was removed. HpD as the photosensitizer, which was diluted by RPMI
1640 incubation media to a concentration of 0.004 mg/ml, was added to the
wells. The culture plates was then placed in the 5% CO2 incubator at
37℃ and completely protected from light.
About 4 hours later six of the plates were illuminated by 150mW/cm2 laser for 10s, 20s, 30s and 75 mW/cm2 laser for 20s, 40s, and 60s respectively while the
other one plate was still kept in protection of light as a control group. After
illuminating the culture plates were placed back in the incubator for 24 hours
and then 0.1 mg diphenylterrazolium bromide (Sigma, St Louis, MO, USA) was
added to the wells before another 4 hoursÕ culture. The supernatant fluid was removed when the culture was completed and 0.15 ml
dimethylsufoxide was added. Culture plates were oscillation slightly for 10 min
and the optical density (OD) of all the wells was measured by an Elisa (318-MC, Xinke Inc, Shanghai, China). The fraction
cell surviving was defined as the ratio of the mean OD of experiment groups to
the control group.
C.
Study on the PDT impetus
The theory of oxygen
diffusion from capillaries has been well established since Krogh, 1919
presented his analytical prediction of how the delivery from vessels was
governed. Since that time, researchers have tried to exploit this model to better
interpret the oxygen diffusion and consumption processes in tissues. It is
accepted that oxygen diffuses away from the high relative concentration in the
vessel to regions of tissue with lower concentration. According to these
models, The equation describing PDT process can be developed as follow:
(1)
where C (r) is
the oxygen concentration at position r, D is the diffusion
coefficient for oxygen in tissue, which is generally taken to be 2«10-5cm2s-1(Pogure
et al, 2001). Γmet, Γpdt, s
are the metabolic oxygen consumption rate, the PDT oxygen consumption rate and
the supply of oxygen at each point r respectively, and all vary with C
(r). According to the Michaelis-Menten model (Tang, 1933), we have
deduced the expression of Γmet (Xu, 2004):
(2)
Γpdt has been given in the fore studies by:
(3)
kot is the bimolecular rate of
triplet quenching by triplet oxygen, koa is the rate of chemical
reaction between singlet
oxygen and unspecified
substrate [A], kos is the rate of chemical reaction between singlet oxygen and the photosensitizer, which always seems to
be 0. And kp is the decay rates of the photosensitizer triplet, respectively. Γ0 is a constant that describes
the initial rate of photochemical oxygen consumption and changes linearly with the light fluence rate (Nichols and Foster 1994, Geogakoudi et al 1997).
Setting values of all the parameter can be found in the paper of Mitra et al,
2000. Equation (3) indicates that PDT will stop at a quite low oxygen concentration
(<<kp / kot).
There
is a little trouble in defining s. First, during PDT there is a similar arterial
blood oxygen level with that before PDT, while the venous blood oxygen concentration
decreases much after the beginning of PDT (Guyton 1981, Slonim and Hamilton,
1981). So there is a higher oxygen supply during PDT than before. Second, the
higher oxygen concentration at the outer vascular wall, the higher blood oxygen
supply occurs. Considering these two factors, we define s by (Xu, 2004):
(4)
Cout(t) is the oxygen concentration
at the outer vascular wall at time t after the beginning of PDT. α
is a constant which can be set as 1~3.
RBCCD changes of venule and arteriole
both occurred under the illumination of 75mW/cm2 and 150mW/cm2
laser. Data collected from the image playback of experiment groups were summarized
in Figure 1. First, the data
obtained from the observation of arteriole were shown in Figure 1A, followed by the data obtained from the observation of
arteriole shown in Figure1B. In Figure 1A, there was an indication that
under the low fluence rate illumination there occurred less microvasculature
damage than high fluence rate in the early period of PDT, while there was no significant
difference between the two kinds of illumination near the end of the treatment.
Arteriole RBCCDrel was obviously lower under 150mW/cm2
illumination than 75mW/cm2 when light dose is 36 J/cm2 (p=0.0031),
54 J/cm2 (p=0.0024) and 72 J/cm2 (p=0.036).
The administration of light dose up to 90 J/cm2 and above seemed to
make similar damages to the arteriole at both light fluence rate. For the light
dose of 18 J/cm2 increase of RBCCDrel occurred
under 150 mW/cm2 illumination. That might due to the physiological reaction
to the high light fluence rate. The RBCCDrel of the venule
decreased more quickly against the light dose than that of the arteriole as shown
in Figure 1B, while no statistically
significant difference in the RBCCDrel of the venule was observed
under 150mW/cm2 and 75mW/cm2 illumination though one
point at the light dose of 54 J/cm2 gave some peradventure. It was
observed that under the illumination of 75mW/cm2 light the RBCCD of
venules dropped slowly when the illuminated fluence was less than 54 J/cm2,
but rapidly when between 54 J/cm2 and 72 J/cm2. Therefore
we could assume that at 75 mW/cm2 the threshold energy dose causing
the vessels damaged severely was between 54 J/cm2 and 72 J/cm2.
Similarly, at 150 mW/cm2 that threshold might be between 36 J/cm2
and 54 J/cm2. The difference of the two thresholds might do some
contribution to the exception at 54 J/cm2.
To determine the PDT induced
direct MDAMB 543 cells killing at various fluence rates the survival rates were
examined. The mean OD valuewas measured as the scale of the
fraction surviving. For control group it was the average OD of 82 wells in the
control plate. OD value of each well in the experiment plates was measured and normalized to the mean control value. For the 150mW/cm2 illuminated group the wells number of each plate was 36 and for OD 75 mW/cm2 illuminated group it was 38. The illuminating light dose of both groups was 1.5 J/cm2,
3 J/cm2, 4.5 J/cm2. Mean normalized OD value and SD of each
plate were calculated and summarized in Figure
2. The surviving fraction was 0.624 versus 0.526(1.5 J/cm2),
0.516 versus 0.384(3 J/cm2), and 0.319 versus 0.219(4.5 J/cm2)
under 150mW/cm2 versus 75mW/cm2 illuminating. It was recognized in a statistic way that the MDAMB 543 cells survival
fractions under fluence rate of 75mW/cm2 was less than that under
150 mW/cm2, indicating more effective cell killing under lower
fluence rate illumination in PDT.

Figure 1. RBCCDrel
changes against the light dose in different
fluence rates for arteriole (A) and
venule (B). Values are means±SD of
10 observation results in each experiment group. Those data points that show, based on the
Wilcoxon signed-ranks test, a statistically significantly difference between
the 75 mW/cm2
group and 150 mW/cm2 group are indicated with an asterisk (*).

Figure 2. Cell fraction surviving after illuminating with light dose of 1.5
J/cm2, 3 J/cm2, 4.5 J/cm2 in PDT. Values were experimental
OD normalized to the control group that was protected from light. Cell fraction
surviving of the two experiment groups were significantly different (p=0.041,
0.033, 0.021).
The initial oxygen
concentration at some points in a range of 100μm surrounding the vascular,
including the point just at the outer wall Cout(0), could be
obtained from the experimental study of Tsai et al, 1998. We expanded the range
through fitting those points and got the initial oxygen distributing in a range
of 1.5mm. Crank-Nicolson method was employed to solve equation (1) starting
from those initial values. The variety of oxygen concentration against time t
and space r was displayed by Figure
3A (fluence rate of 75mW cm-2) and Figure 3B (fluence rate of 150mW cm-2). The oxygen
threshold in the photodynamic reaction was considered to be 3.54μM in Figure 3A and 5.2μM in Figure 3B. This result indicated a more
powerful PDT impetus under low fluence rate than high one. It could be informed
from Figure 3 that photodynamic
reaction could not start in some area where the oxygen concentration was less
than those thresholds. For 75mW/cm2
illuminating the inactive area was region of r>1.16mm and for
150mW/cm2 illuminating it is r>0.8mm. It is 40.2% and
71.6% of the model tumor volume respectively.
From this work it can be
recognized that light fluence rate can improve the therapy effect through the
blood oxygen supply, the cell killing rate and the reaction impetus. Low
fluence rate treatments can be more effective in decreasing vascular lesions
than high fluence rate treatments, if the same light fluence is applied during
the PDT process. Other studies have also concluded lower fluence rate
treatments can preserve the status of oxygen for a more effective PDT (Tromberg
et al 1990; Foster et al 1991; Sitnik and Henderson 1998; Sitnik et al 1998),
and it has been recognized that light fluence rates play a major role in the
tumor oxygenation status during PDT exposure. Our work explains the mechanism
of oxygen preservation under low fluence illumination in PDT to some extent. It
can be concluded from Figure 1 that
lower fluence brings less microvasculature damage during the PDT process,
though there seems to be no difference in venules at the two different fluence
rates, which may be due to the extremely vulnerable venule circulation. In theory,
less damage to microvasculature indicates timely oxygen supply to recover the
photochemical consumption of oxygen in PDT. As tissue oxygen is one of the
elementary factors of PDT, the timely supply of oxygen is fairly important for
the destruction of tumors.
Some clinical and experimental data have been reported
recently pointing to a significant tumor cure effect (Robinson et al 1998;
Langmack et al 2001). From the result of our cell killing experiment, we can
conclude that lower fluence rate treatments may be more effective in increasing
the killing rate of tumor cells, which directly indicates better local tumor
control. For an experiment performed in vitro, the oxygen consumption of PDT
and the photosensitizer concentration in the medium can be regarded as
constant. Thus the cell killing effect may vary against the photosensitizer bleaching
and singlet oxygen generating, which changes with the light
fluence rate. While recently studies have reported that higher photobleaching
seem to occur under illuminating of lower fluence rate both in vivo and vitro
experiments (Coutier et al 2001; Finlay et al 2004). So we can only contribute
the higher cell killing rate caused by lower fluence rate to higher singlet
oxygen generating. In vitro experiment with sufficient oxygen supplying,
sharply consumption of triplet oxygen caused by high fluence rate illuminating
will increase the chance that excited singlet oxygen return to the ground
state. As a result the possibility that singlet oxygen reaction with the tumor
cell is decreased, means a low cell killing rate.
In the PDT process, the decay rates of the photosensitizer triplet, kp, is decided by the concentration of triplet photosensitizer. Under a
higher fluence rate illuminating, more photosensitizer molecules are excited to
be singlet and triplet status. High irradiance energy causes high frequence of energy level
transition. Consequently the tendency of energy transferring from triplet
photosensitizer to triplet oxygen is wakened. So under higher fluence rate illuminating the bimolecular
rate of triplet quenching by triplet
oxygen, kot, takes a lower value.

Figure 3. Oxygen concentration changes against time t and space r in 75 mW/cm2 (A) and 150 mW/cm2 (B) illuminating PDT. Values are deduced step by step with Crank-Nicolson method from the Krogh model tumor. C(r,0) is obtained through fitting the dates in TsaiÕs paper, 1998.
For the promotion of photodynamic reaction is
positive going with the product of kot and oxygen concentration, there need to be a high
oxygen environment to ensure the proceeding of photodynamic reaction. Similar
viewpoint are presented in appendix equation (A9) by Finlay et al, 2004. As a result PDT under a higher fluence rate will
stop at a higher oxygen concentration threshold. Oxygen concentration ascending
showed in Figure 3 is owned to the
oxygen diffusion in the model tumor. Though
there is no reaction occurring, the light illuminating aggravates the oxygen
diffusion to the inactive
area.
Coutier S, Mitra S, Bezdetnaya
LN, Parache RM, Georgakoudi I, Foster TH and Guillemin F (2001) Effects of fluence rate on cell survival and photobleaching
in meta-tetra-(hydroxyphenyl)chlorin-photosensitized colo 26 multicell tumor
spheroids. Photochem
Photobiol 73, 297-303.
Dougherty TJ, Gomer CJ, Henderson BW, Jori G et al (1998) Photodynamic therapy. J
Natl Cancer Inst 90,889-905.
Fingar VH, Kik PK, Haydon PS,
Cerrito PB, Tseng M, Abang E, Wieman TJ (1999)
Analysis of acute vascular damage after photodynamic therapy using
benzoporphyrin derivative (BPD). Br J
Cancer 79, 1702-1708.
Fingar VH, Wieman TJ, Wiehle
SA, Cerrito PB (1992) The role of
microvascular damage in photodynamic therapy: the effect of treatment on vessel
constriction, permeability and leukocyte adhesion. Cancer Res 52, 4914-4921.
Finlay JC, Soumya M,
Patterson MS, Foster TH (2004)
Photobleaching kinetics of photofrin in vivo and in multicell tumour spheroids
indicate two simultaneous bleaching mechanisms. Phys Med Biol 49, 4837-4860.
Foster TH (1990) Magnetic resonance, optical , and
mathematical methods applied to studies in the biological physics of tissues.
Ph.D theisis of the University of Rochester.
Foster TH, Hartley DF,
Nicholas MG, Halif R (1993) Fluence
rate effects in photodynamic therapy of multicell tumour spheroids. Cancer Res 53, 1249-1254.
Foster TH, Murant RS, Bryant
RG, Knox RS, Gibson SL, Halif R (1991)
Oxygen consumption and diffusion effects in photodynamic therapy. Radiat Res 126, 296-303.
Geogakoudi I, Nichols MG and
Foster TH (1997) The mechanism of
photofrin photobleaching and its consequences for photodynamic dosimetry. Photochem
Photobiol 65, 135-144.
Guyton AC (1981) Physiology: Textbook of Medical
Physiology, 6th edn. Saunders, Philadelphia, PA.
Henderson BW, Busch TM,
Vaughan LA, Frawley NP, Babich D, Sosa TA, Zollo JD, Dee AS, Cooper MT,
Bellnier DA, Greco WR, Oseroff AR (2000)
Photofrin Photodynamic Therapy Can Significantly Deplete or Preserve
Oxygenation in Human Basal Cell Carcinomas during Treatment, Depending on
Fluence Rate. Cancer Res 60,
525-529.
Krogh A (1919) The number and distribution of capillaries in muscles with
calculations of the oxygen pressure head necessary for supplying the tissue. J Physiol 52, 409-415.
Langmack K, Mehta R, Twyman
P, Norris P (2001) Topical
photodynamic therapy at low fluence rates-theory and practice. J Photochem Photobiol B. 60, 37-43.
Mitra S, Foster TH (2000) Photochemical Oxygen Consumption
Sensitized by a Porphyrin Phosphorescent Probe in Two Model Systems. Biophys J 78, 2597-2605.
Nichols MG and Foster TH (1994) Oxygen diffusion and reaction
kinetics in the photodynamic therapy of multicell tumour spheroids. Phys Med Biol 39, 2161-2181.
Pogure BW, OÕHara JA, Wilmot
CM, Paulsen KD and Swartz HM (2001)
Estimation of oxygen distribution in RIF-1 tumors by diffusion model-based
interpretation of pimonidazole hypoxia and eppendorf measurements. Radiat Res 155, 15-25.
Robinson DJ, de Bruijn HS,
van der Veen N, Stringer MR, Brown SB, Star WM (1998) Fluorescence photobleaching of ALA-induced protoporphyrin IX
during photodynamic therapy of normal hairless mouse skin: the effect of light
dose and irradiance and the resulting biological effect. Photochem
Photobiol 67, 140-146.
Rosenthal DJ, Glatstein E (1994) Clinical applications of
photodynamic therapy. Ann Med 26,
405-409.
Schunck T, Poulet P (2000) Oxygen consumption through
metabolism and photodynamic reactions in cell cultured on microbeads. Phys Med Biol 45, 103-119.
Sitnik TM, Hampton JA,
Henderson BW (1998) Reduction of
tumour oxygenation during and after photodynamic therapy in vivo: effects of
fluence rate. Br J Cancer 77,
1386-1394.
Sitnik TM, Henderson BW (1998) The effect of fluence rate on
tumor and normal tissue responses to photodynamic therapy. Photochem
Photobiol 67, 462-466.
Slonim NB and Hamilton LA (1981) In Respiratory Physiology, 4th
edn. Mosby,St Louis. MO.
Tang PS (1933) On the rate of oxygen consumption by tissues and lower
organisms as a function of oxygen tension. Q
Rev Biol 8, 260-274.
Tromberg BJ, Orenstein A,
Kimel S, Barker SJ, Hyat J, Nelson JS, Berns MW (1990) In vivo tumour oxygen tension measurements for the evaluation
of the efficiency of photodynamic therapy. Photochem
Photobiol 52, 375-385.
Tsai AG, Friesenecker B,
Mazzoni MC, Kerger H, Buerk DG, Johnson PC and Intaglietta M (1998) Microvascular and tissue oxygen
gradients in the rat mesentery. Proc
Natl Acad Sci U S A95,6590-6595.
Veenhuizen RB, Stewart FA (1995) The importance of fluence rate
photodynamic therapy: was there a parallel with ionizing radiation dose-rate
effects? Radiother Oncol 37, 131-135.
Xu T (2004) The theoretical and experimental studies on the tumor oxygen
content in photodynamic therapy. PhD thesis, Tianjin University.
Xu T, Wu X, Li YX (2005) Application of lower fluence rate for less microvasculature
damage and more cell killing during photodynamic therapy. Lasers Med Sci 19, 257-262.